Khavinson peptide bioregulators (Epithalon, Pinealon)

Khavinson short peptide bioregulators are a family of ultrashort di-, tri- and tetrapeptides studied for their proposed role in tissue-specific gene-expression regulation. This article surveys the research lineage, theory and best-known sequences strictly as in-vitro and preclinical literature for qualified researchers.

Origin: the St. Petersburg school

The short peptide bioregulator concept originates with Professor Vladimir Khavinson and the St. Petersburg Institute of Bioregulation and Gerontology, building on Soviet-era work that began in the 1970s-1980s with peptide extracts from animal tissues such as the pineal gland and thymus. Researchers fractionated these complex polypeptide extracts to identify the minimal bioactive fragments responsible for the observed effects, then synthesized those fragments as defined short peptides. Epithalon (Ala-Glu-Asp-Gly, AEDG), for example, was characterized as a synthetic tetrapeptide modeled on the pineal extract epithalamin. This lineage is distinctively CIS-native: the bulk of the primary literature is authored by this single research group and published over several decades. For researchers, that concentration of provenance is itself a methodological consideration, since independent replication outside the originating institutions remains comparatively limited in the peer-reviewed record. The compounds are studied here only as laboratory reagents and literature subjects, not as products with any human or animal application.

Peptide-bioregulation theory

The theoretical framework underpinning these compounds is peptide bioregulation: the hypothesis that very short endogenous peptides act as signaling molecules that help maintain tissue homeostasis by modulating the expression of specific genes. In this model, each tissue is associated with characteristic regulatory peptides, and the corresponding synthetic short peptide is proposed to influence the same gene programs in cell-culture and animal models. A central and debated mechanistic claim is that certain ultrashort peptides can enter cells and the nucleus and interact directly with DNA or chromatin in a sequence-dependent manner, rather than acting solely through cell-surface receptors. Computational and spectroscopic studies from the group describe how charged residues, such as arginine, might contact the DNA backbone while acidic residues provide sequence specificity. This remains a research hypothesis: the experimental support is concentrated in in-vitro systems and rodent studies, and the precise molecular details continue to be investigated and critiqued in the literature.

Telomerase and cellular-senescence research

The most frequently cited mechanistic line concerns Epithalon (AEDG) and telomere biology. Published cell-culture work reported that exposure of human somatic cells, including fibroblasts, was associated with induction of telomerase activity and elongation of telomeres in vitro, alongside extended proliferative capacity of the cultures. These observations placed AEDG within the broader scientific conversation on replicative senescence, the Hayflick limit and telomere maintenance. Related rodent studies from the originating group reported effects on melatonin rhythms and lifespan endpoints in laboratory animals. Researchers evaluating this body of work generally note important caveats: telomerase induction findings derive largely from specific in-vitro systems, sample sizes in animal work were often small, and independent confirmation in Western laboratories is sparse. As such, the telomerase and senescence data are best treated as hypothesis-generating preclinical findings that frame in-vitro experimental design rather than as settled biology.

Representative sequences and research scope

Two compounds illustrate the family. Epithalon, alanyl-glutamyl-aspartyl-glycine (Ala-Glu-Asp-Gly, AEDG), is the tetrapeptide derived from pineal extract and is the principal subject of the telomerase literature. Pinealon, glutamyl-aspartyl-arginine (Glu-Asp-Arg, EDR), is a tripeptide studied in neuronal cell and rodent models for proposed gene-expression and neuroprotection-related endpoints, including reports framed around antioxidant and apoptosis-related pathways in cell culture. Both are short, fully synthetic sequences that are convenient to characterize by HPLC-MS and to handle as defined research reagents. For laboratory work, the meaningful parameters are identity, purity and a Certificate of Analysis, not any applied claim. Note that these bioregulators are unrelated to GLP-1 receptor agonists; Peptiko does not supply Tirzepatide, Semaglutide or Retatrutide. All material here is provided for in-vitro and preclinical research by qualified researchers and laboratories, with no human-use, animal-use, diagnostic or therapeutic guidance expressed or implied.

Related guides

What are peptides? HPLC purity testing explained How to read a COA